未登录.png)
分享.png)
收藏分享 收藏 分享 收藏 分享 收藏 分享 收藏 Disitamab vedotin (DV) plus toripalimab (T) in unresectable locally advanced or metastatic urothelial carcinoma (la/mUC): Long-term outcomes from a phase Ib/II studyDisitamab vedotin (DV) 联合 toripalimab (T) 治疗不可切除局部晚期或转移性尿路上皮癌 (la/mUC) 的长期疗效：一项 Ib/II 期研究的结果
Zhou, L.; Yang, K.; Zhang, S.; Yan, X.; Li, S.; Xu, H.; Li, J.; Chi, Z.; Mao, L.; Lian, B.; Bixia, T.; Wang, X.; Guo, H.; He, Z.; Guo, J.; Sheng, X. 分享 收藏 Transient behaviors in a spectrum-tailored all-PM NALM mode-locked fiber laserZhang, Han; Xia, Handing; Zheng, Junwen; Li, Jianbin; Zhang, Fan; Fan, Mengqiu; Xiang, Xiangjun; Tian, Xiaocheng; Huang, Zhimeng; Zhang, Rui; Li, Ping; Peng, Zhitao; Hu, Dongxia; Zhu, Qihua 分享 收藏 Glass-Forming Ability, Mechanical Properties, and Energetic Characteristics of ZrCuNiAlNbHfY Bulk Metallic GlassesZrCuNiAlNbHfY大块金属玻璃的玻璃形成能力，机械性能和能量特性Yu, Xin; Li, Jianbin; Zhang, Kaichuang; Zhang, Huijie; Wang, Hao; Fang, Yuanhang; Ma, Yusong; Wang, Zhenxiong; Zhang, Xinggao; Gai, Xiqiang 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in ChinaZhang, Shaohua; Li, Jianbin; Xu, Ruonan; Chen, Qianjun; Sun, Gang; Lin, Ying; Cao, Yali; Chen, Yiding; Geng, Cuizhi; Teng, Yuee; Nie, Jianyun; Li, Xinzheng; Xu, Guiying; Liu, Xinlan; Jin, Feng; Fan, Zhimin; Luo, Ting; Liu, Hong; Wang, Fu-sheng; Jiang, Zefei 分享 收藏 分享 收藏 Pembrolizumab in patients of Chinese descent with microsatellite instability-high/mismatch repair deficient advanced solid tumors: KEYNOTE-158Wu, X.; Mao, Y.; Xu, N.; Bai, Y.; Wang, D.; Chen, X.; Yin, X.; Deng, Y.; Yang, J.; Zhang, J.; Tang, J.; Huang, Y.; Li, J.; Xu, M.; Li, N.; Mao, Y.; Gozman, A.; Xu, J. 分享 收藏 分享 收藏 分享 收藏 SKB264 (MK-2870) in previously treated hormone receptor-positive (HR+)/ HER2-negative metastatic breast cancer (mBC): Results from a phase I/II, single-arm, basket trialOuyang, Q.; Yin, Y.; Song, L.; Yan, M.; Wu, X.; Tong, Z.; Liu, Y.; Wang, X.; Jin, X.; Diao, Y.; Liu, G.; Ge, J.; Li, J. 分享 收藏 Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021Li, Jianbin; Zhou, Jifang; Wang, Haibo; Liu, Zhenzhen; Fan, Zhimin; Liu, Yinhua; Geng, Cuizhi; Xiao, Yue; Jiang, Zefei 分享 收藏 HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesisJiang, Qiwei; Zhang, Deyu; Liu, Juan; Liang, Chaoyang; Yang, Ronghui; Zhang, Cheng; Wu, Jun; Lin, Jing; Ye, Tianxing; Ding, Lihua; Li, Jianbin; Gao, Shan; Li, Binghui; Ye, Qinong 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
